Other analysts have also recently issued reports about the company. Jefferies Group reissued a buy rating and issued a $113.00 price target (down from $125.00) on shares of Adeptus Health in a research report on Monday, July 11th. KeyCorp reissued a buy rating on shares of Adeptus Health in a research report on Thursday, June 2nd. Zacks Investment Research cut Adeptus Health from a buy rating to a strong sell rating in a research report on Wednesday, July 13th. Morgan Stanley reaffirmed a hold rating on shares of Adeptus Health in a research report on Tuesday, May 31st. Finally, Goldman Sachs Group Inc. set a $80.00 price objective on Adeptus Health and gave the company a buy rating in a research report on Thursday, September 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $86.50.
Adeptus Health (NYSE:ADPT) opened at 41.85 on Thursday. Adeptus Health has a 12 month low of $35.33 and a 12 month high of $90.71. The stock has a market capitalization of $684.25 million, a PE ratio of 6.37 and a beta of 0.96. The stock has a 50 day moving average price of $41.63 and a 200 day moving average price of $53.04.
Adeptus Health (NYSE:ADPT) last issued its quarterly earnings results on Thursday, July 21st. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.51 by $0.03. Adeptus Health had a return on equity of 14.74% and a net margin of 22.99%. The company earned $100.20 million during the quarter, compared to the consensus estimate of $93.92 million. During the same period in the prior year, the firm earned $0.44 earnings per share. The business’s revenue for the quarter was up 36.2% compared to the same quarter last year. On average, equities research analysts forecast that Adeptus Health will post $2.46 earnings per share for the current fiscal year.
Several institutional investors have recently added to or reduced their stakes in ADPT. Texas Permanent School Fund boosted its position in Adeptus Health by 94.0% in the first quarter. Texas Permanent School Fund now owns 9,584 shares of the company’s stock valued at $532,000 after buying an additional 4,645 shares during the last quarter. Seven Eight Capital LLC purchased a new position in Adeptus Health during the first quarter valued at $101,000. Springbok Capital Management LLC purchased a new position in Adeptus Health during the first quarter valued at $151,000. Prudential Financial Inc. boosted its position in Adeptus Health by 60.8% in the first quarter. Prudential Financial Inc. now owns 125,932 shares of the company’s stock valued at $6,995,000 after buying an additional 47,632 shares during the last quarter. Finally, Pioneer Investment Management Inc. purchased a new position in Adeptus Health during the fourth quarter valued at $1,992,000.
About Adeptus Health
Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.
Receive News & Ratings for Adeptus Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.